Grandner said this will be an important area to explore going forward because it's known that short sleep duration is associated with poor health effects, including weight gain and obesity, diabetes and cardiovascular disease. Cleveland Clinic's Lappe said: I think this piece of the study is actually good. There are a lot of early intervention programs in Head Start and preschools, and education directly to parents that may be starting to pay off. The increased risk is equal to about seven extra cases of atrial fibrillation per 1,000 new users of cox-2 inhibitors and about four extra cases per 1,000 new users of non-selective NSAIDs, according to the researchers at Aarhus University Hospital.

Although commonplace, women shouldn't accept recurrent urinary tract infections as a normal part of aging, Wu said. Talk to a gynecologist or urologist to find out what kinds of therapies are available, she said. There are treatments besides antibiotics. Dr. Amy Rosenman, a specialist in urogynecology and pelvic surgery in Santa Monica, Calif., and health sciences clinical professor at the University of California Los Angeles David Geffen School of Medicine, said the study findings ring true in practice. Attention-deficit/hyperactivity disorder affects between 5 percent and 10 percent of all children in the United States and Europe, according to background information in the study. The U.S. National Institute of Mental Health says that the primary symptoms of the disorder are hyperactive and impulsive behavior, and inattention. In general, girls tend to have more trouble with paying attention, while boys tend to be more hyperactive, said Zoega. The application pending at FDA is based on results from an extensive clinical development program. Oralair? has been studied in double-blind, placebo-controlled trials, in both Europe and the United States in over 1,500 adults and children. Positive results were achieved in these trials designed to demonstrate that pre-seasonal and co-seasonal treatment with grass allergy immunotherapy reduces patients? allergy symptoms and their need for symptom-relieving medication and provides a sustained long-term effect after completion of treatment. Oralair? was generally well tolerated and the most common treatment-emergent adverse events (greater than 10%) were application site reactions including oral pruritus and throat irritation.